These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 27554438)
21. Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians. Keshk WA; Zineldeen DH; El-Heneedy YA; Ghali AA Neurol Sci; 2018 Jun; 39(6):1093-1104. PubMed ID: 29637447 [TBL] [Abstract][Full Text] [Related]
22. Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes. Song FY; Wu MH; Zhu LH; Zhang ZQ; Qi QD; Lou CL Mol Neurobiol; 2015 Dec; 52(3):1330-1340. PubMed ID: 25341475 [TBL] [Abstract][Full Text] [Related]
23. Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus. Villela-Torres ML; Higareda-Mendoza AE; Gómez-García A; Alvarez-Paredes AR; García-López E; Stenvikel P; Gu HF; Rashid-Qureshi A; Lindholm B; Alvarez-Aguilar C Arch Med Res; 2018 Jan; 49(1):36-43. PubMed ID: 29665969 [TBL] [Abstract][Full Text] [Related]
24. Copeptin as a prognostic biomarker in acute myocardial infarction. Lattuca B; Sy V; Nguyen LS; Bernard M; Zeitouni M; Overtchouk P; Yan Y; Hammoudi N; Ceccaldi A; Collet JP; Kerneis M; Diallo A; Montalescot G; Silvain J Int J Cardiol; 2019 Jan; 274():337-341. PubMed ID: 30217427 [TBL] [Abstract][Full Text] [Related]
25. A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score. De Marchis GM; Dankowski T; König IR; Fladt J; Fluri F; Gensicke H; Foerch C; Findling O; Kurmann R; Fischer U; Luft A; Buhl D; Engelter ST; Lyrer PA; Christ-Crain M; Arnold M; Katan M Neurology; 2019 Mar; 92(13):e1517-e1525. PubMed ID: 30824558 [TBL] [Abstract][Full Text] [Related]
26. Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study. Greisenegger S; Segal HC; Burgess AI; Poole DL; Mehta Z; Rothwell PM Stroke; 2015 Nov; 46(11):3117-23. PubMed ID: 26451023 [TBL] [Abstract][Full Text] [Related]
27. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. De Marchis GM; Katan M; Weck A; Fluri F; Foerch C; Findling O; Schuetz P; Buhl D; El-Koussy M; Gensicke H; Seiler M; Morgenthaler N; Mattle HP; Mueller B; Christ-Crain M; Arnold M Neurology; 2013 Apr; 80(14):1278-86. PubMed ID: 23468541 [TBL] [Abstract][Full Text] [Related]
28. Circulating FABP4 (Fatty Acid-Binding Protein 4) Is a Novel Prognostic Biomarker in Patients With Acute Ischemic Stroke. Tu WJ; Zeng XW; Deng A; Zhao SJ; Luo DZ; Ma GZ; Wang H; Liu Q Stroke; 2017 Jun; 48(6):1531-1538. PubMed ID: 28487339 [TBL] [Abstract][Full Text] [Related]
29. Elevated plasma levels of copeptin linked to diabetic retinopathy in type 2 diabetes. Zhao Q; Wu XX; Zhou J; Wang X Mol Cell Endocrinol; 2017 Feb; 442():106-112. PubMed ID: 27940301 [TBL] [Abstract][Full Text] [Related]
30. Copeptin levels are associated with organ dysfunction and death in the intensive care unit after out-of-hospital cardiac arrest. Ristagno G; Latini R; Plebani M; Zaninotto M; Vaahersalo J; Masson S; Tiainen M; Kurola J; Gaspari F; Milani V; Pettilä V; Skrifvars MB; Crit Care; 2015 Mar; 19(1):132. PubMed ID: 25886856 [TBL] [Abstract][Full Text] [Related]
31. Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. Fenske W; Wanner C; Allolio B; Drechsler C; Blouin K; Lilienthal J; Krane V; J Am Soc Nephrol; 2011 Apr; 22(4):782-90. PubMed ID: 21415158 [TBL] [Abstract][Full Text] [Related]
32. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke. Chang L; Yan H; Li H; Song Z; Gui Y; Yan Z; Li T; Duan D Neuroreport; 2014 Sep; 25(13):985-90. PubMed ID: 25102374 [TBL] [Abstract][Full Text] [Related]
33. Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke. Qi AQ; Li Y; Liu Q; Si JZ; Tang XM; Zhang ZQ; Qi QD; Chen WB Free Radic Biol Med; 2015 Mar; 80():129-35. PubMed ID: 25555670 [TBL] [Abstract][Full Text] [Related]
35. Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction. Zellweger C; Wildi K; Twerenbold R; Reichlin T; Naduvilekoot A; Neuhaus JD; Balmelli C; Gabutti M; Al Afify A; Ballarino P; Jäger C; Druey S; Hillinger P; Haaf P; Vilaplana C; Darbouret B; Ebmeyer S; Rubini Gimenez M; Moehring B; Osswald S; Mueller C Int J Cardiol; 2015; 190():190-7. PubMed ID: 25920022 [TBL] [Abstract][Full Text] [Related]
36. Serum levels of copeptin are associated with type 2 diabetes and diabetic complications in Chinese population. Zhu FX; Wu HL; Tu KS; Chen JX; Zhang M; Shi C J Diabetes Complications; 2016; 30(8):1566-1570. PubMed ID: 27497684 [TBL] [Abstract][Full Text] [Related]
37. Elevated Serum and Cerebrospinal Fluid Free Fatty Acid Levels Are Associated with Unfavorable Functional Outcome in Subjects with Acute Ischemic Stroke. Duan XX; Zhang GP; Wang XB; Yu H; Wu JL; Liu KZ; Wang L; Long X Mol Neurobiol; 2017 Apr; 54(3):1677-1683. PubMed ID: 26873852 [TBL] [Abstract][Full Text] [Related]
38. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke. Zhu YY; Zhang JL; Liu L; Han Y; Ge X; Zhao S Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30038059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]